Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tumors"" wg kryterium: Temat


Tytuł :
The therapeutic efficacy of 177Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis.
Autorzy :
Wang LF; Department of PET/CT, First Affiliated Hospital, Harbin Medical University, Harbin, China.
Lin L
Wang MJ
Li Y
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Mar; Vol. 99 (10), pp. e19304.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Neuroendocrine Tumors/*drug therapy
Octreotide/*analogs & derivatives
Radiopharmaceuticals/*therapeutic use
Humans ; Neuroendocrine Tumors/pathology ; Octreotide/administration & dosage ; Octreotide/therapeutic use ; Radiopharmaceuticals/administration & dosage ; Response Evaluation Criteria in Solid Tumors
Czasopismo naukowe
Tytuł :
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.
Autorzy :
Martin-Broto J; Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain; Institute of Biomedicine of Seville (University Hospital Virgen del Rocio; Spanish National Research Council; University of Seville), Seville, Spain. Electronic address: .
Cruz J; Medical Oncology Department, University Hospital of Canarias, Tenerife, Spain.
Penel N; Department of Medical Oncology, Centre Oscar Lambret, Lille Medical School, Lille University, Lille, France.
Le Cesne A; Gustave Roussy, Villejuif, France.
Hindi N; Medical Oncology Department, University Hospital Virgen del Rocio, Seville, Spain; Institute of Biomedicine of Seville (University Hospital Virgen del Rocio; Spanish National Research Council; University of Seville), Seville, Spain.
Luna P; Medical Oncology Department, University Hospital Son Espases, Mallorca, Spain.
Moura DS; Institute of Biomedicine of Seville (University Hospital Virgen del Rocio; Spanish National Research Council; University of Seville), Seville, Spain.
Bernabeu D; Radiology Department, University Hospital La Paz, Madrid, Spain.
de Alava E; Institute of Biomedicine of Seville (University Hospital Virgen del Rocio; Spanish National Research Council; University of Seville), Seville, Spain; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Seville, Spain.
Lopez-Guerrero JA; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain; Department of Basic Medical Sciences, School of Medicine, Catholic University of Valencia San Vicente Martir, Valencia, Spain.
Dopazo J; Clinical Bioinformatics Area, Fundación Progreso y Salud, University Hospital Virgen del Rocio, Seville, Spain; Bioinformatics in Rare Diseases, Centro de Investigación Biomédica en Red de Enfermedades Raras, Fundación Progreso y Salud, University Hospital Virgen del Rocio, Seville, Spain; Spanish National Bioinformatics Institute, Fundación Progreso y Salud, Hospital Virgen del Rocío, Seville, Spain.
Peña-Chilet M; Clinical Bioinformatics Area, Fundación Progreso y Salud, University Hospital Virgen del Rocio, Seville, Spain; Bioinformatics in Rare Diseases, Centro de Investigación Biomédica en Red de Enfermedades Raras, Fundación Progreso y Salud, University Hospital Virgen del Rocio, Seville, Spain.
Gutierrez A; Haematology Department, University Hospital Son Espases, Mallorca, Spain.
Collini P; Soft Tissue and Bone Pathology, Histopathology and Pediatric Pathology Unit, Diagnostic Pathology and Laboratory Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy.
Karanian M; Department of Biopathology Centre Leon Berard, Cancer Research Center of Lyon, Lyon, France.
Redondo A; Department of Medical Oncology, University Hospital La Paz, Madrid, Spain.
Lopez-Pousa A; Medical Oncology Department, Sant Pau Hospital, Barcelona, Spain.
Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, Candiolo, Italy.
Diaz-Martin J; Institute of Biomedicine of Seville (University Hospital Virgen del Rocio; Spanish National Research Council; University of Seville), Seville, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Seville, Spain.
Marcilla D; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain.
Fernandez-Serra A; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Gonzalez-Aguilera C; Institute of Biomedicine of Seville (University Hospital Virgen del Rocio; Spanish National Research Council; University of Seville), Seville, Spain.
Casali PG; Cancer Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy.
Blay JY; Centre Leon Berard, Université de Lyon, Lyon, France.
Stacchiotti S; Cancer Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale Tumori, Milan, Italy.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Mar; Vol. 21 (3), pp. 456-466. Date of Electronic Publication: 2020 Feb 14.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Protein Kinase Inhibitors/*therapeutic use
Pyrimidines/*therapeutic use
Solitary Fibrous Tumors/*drug therapy
Sulfonamides/*therapeutic use
Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Prospective Studies ; Response Evaluation Criteria in Solid Tumors ; Solitary Fibrous Tumors/pathology ; Survival Rate
Czasopismo naukowe
Tytuł :
Neuroendocrine Tumors: Imaging of Treatment and Follow-up.
Autorzy :
Migut AE; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Kaur H; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Avritscher R; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Department of Interventional Radiology, 1400 Pressler Street, Unit 1471, Houston, TX 77030, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiologic clinics of North America [Radiol Clin North Am] 2020 Nov; Vol. 58 (6), pp. 1161-1171.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Chemotherapy, Cancer, Regional Perfusion/*methods
Molecular Targeted Therapy/*methods
Multimodal Imaging/*methods
Neuroendocrine Tumors/*diagnostic imaging
Neuroendocrine Tumors/*therapy
Combined Modality Therapy ; Disease-Free Survival ; Embolization, Therapeutic/methods ; Female ; Humans ; Male ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Neuroendocrine Tumors/mortality ; Neuroendocrine Tumors/pathology ; Positron Emission Tomography Computed Tomography/methods ; Prognosis ; Risk Assessment ; Survival Analysis
Czasopismo naukowe
Tytuł :
PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
Autorzy :
Remes SM; Department of Pathology, Helsinki University Hospital and HUSLAB, University of Helsinki, Helsinki, Finland.
Leijon H; Department of Pathology, Helsinki University Hospital and HUSLAB, University of Helsinki, Helsinki, Finland.
Vesterinen T; Department of Pathology, Helsinki University Hospital and HUSLAB, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Louhimo J; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Pulkkinen V; Heart and Lung Center, Division of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ezer S; Research Programs Unit, Program for Molecular Neurology, University of Helsinki, Helsinki, Finland.
Kere J; Research Programs Unit, Program for Molecular Neurology, University of Helsinki, Helsinki, Finland.; Folkhälsan Institute of Genetics, Helsinki, Finland.; Department of Biosciences and Nutrition, Karolinska Institutet, Novum, Stockholm, Sweden.
Haglund C; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine, Research Program Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Arola J; Department of Pathology, Helsinki University Hospital and HUSLAB, University of Helsinki, Helsinki, Finland.
Pokaż więcej
Źródło :
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2020 Nov; Vol. 128 (11), pp. 563-572. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article
MeSH Terms :
Adrenal Gland Neoplasms/*genetics
Carcinoma, Neuroendocrine/*genetics
Gastrointestinal Neoplasms/*genetics
Lung Neoplasms/*genetics
Neuroendocrine Tumors/*genetics
Paraganglioma/*genetics
Pheochromocytoma/*genetics
Proprotein Convertase 2/*genetics
Adenocarcinoma/diagnosis ; Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Adrenal Gland Neoplasms/diagnosis ; Adrenal Gland Neoplasms/pathology ; Adrenal Gland Neoplasms/surgery ; Biomarkers, Tumor/genetics ; Carcinoma, Neuroendocrine/diagnosis ; Carcinoma, Neuroendocrine/pathology ; Carcinoma, Neuroendocrine/surgery ; Chromogranin A/genetics ; Female ; Gastrointestinal Neoplasms/diagnosis ; Gastrointestinal Neoplasms/pathology ; Gastrointestinal Neoplasms/surgery ; Gene Expression ; Humans ; Immunohistochemistry ; Ki-67 Antigen/genetics ; Lung Neoplasms/diagnosis ; Lung Neoplasms/pathology ; Lung Neoplasms/surgery ; Lymphatic Metastasis ; Male ; Neoplasm Staging ; Neuroendocrine Tumors/diagnosis ; Neuroendocrine Tumors/pathology ; Neuroendocrine Tumors/surgery ; Paraganglioma/diagnosis ; Paraganglioma/pathology ; Paraganglioma/surgery ; Pheochromocytoma/diagnosis ; Pheochromocytoma/pathology ; Pheochromocytoma/surgery ; Thyroid Neoplasms/diagnosis ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Multimodality Imaging of Neuroendocrine Tumors.
Autorzy :
Galgano SJ; Department of Radiology, Section of Abdominal Imaging, University of Alabama at Birmingham, 619 19th Street South, JT N325, Birmingham, AL 35249, USA; Department of Radiology, Section of Molecular Imaging & Therapeutics, University of Alabama at Birmingham, 619 19th Street South, JT N325, Birmingham, AL 35249, USA. Electronic address: .
Sharbidre K; Department of Radiology, Section of Abdominal Imaging, University of Alabama at Birmingham, 619 19th Street South, JT N325, Birmingham, AL 35249, USA.
Morgan DE; Department of Radiology, Section of Abdominal Imaging, University of Alabama at Birmingham, 619 19th Street South, JT N325, Birmingham, AL 35249, USA.
Pokaż więcej
Źródło :
Radiologic clinics of North America [Radiol Clin North Am] 2020 Nov; Vol. 58 (6), pp. 1147-1159. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Clinical Decision-Making/*methods
Multimodal Imaging/*methods
Neuroendocrine Tumors/*diagnostic imaging
Neuroendocrine Tumors/*surgery
Surgery, Computer-Assisted/*methods
Disease-Free Survival ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Neuroendocrine Tumors/mortality ; Neuroendocrine Tumors/pathology ; Positron Emission Tomography Computed Tomography/methods ; Survival Analysis ; Tomography, X-Ray Computed/methods ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
[Hot topic in the comprehensive treatment of pancreatic neuroendocrine tumors].
Autorzy :
Lou WH; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Pokaż więcej
Źródło :
Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2020 Oct 01; Vol. 58 (10), pp. 745-748.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors*/surgery
Neuroendocrine Tumors*/therapy
Pancreatic Neoplasms*/surgery
Pancreatic Neoplasms*/therapy
Combined Modality Therapy ; Humans ; Pancreatectomy
Czasopismo naukowe
Tytuł :
Peptide Receptor Radionuclide Therapy as First-Line Systemic Treatment in Advanced Inoperable/Metastatic Neuroendocrine Tumors.
Autorzy :
Satapathy S; From the Departments of Nuclear Medicine.
Mittal BR; From the Departments of Nuclear Medicine.
Sood A; From the Departments of Nuclear Medicine.
Sood A; From the Departments of Nuclear Medicine.
Kapoor R; Radiotherapy.
Gupta R; General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Sep; Vol. 45 (9), pp. e393-e399.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroendocrine Tumors/*pathology
Neuroendocrine Tumors/*radiotherapy
Octreotide/*analogs & derivatives
Organometallic Compounds/*therapeutic use
Receptors, Peptide/*metabolism
Adolescent ; Adult ; Aged ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neuroendocrine Tumors/metabolism ; Neuroendocrine Tumors/surgery ; Octreotide/therapeutic use ; Progression-Free Survival ; Young Adult
Czasopismo naukowe
Tytuł :
Sequential Duo-Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET/CT Imaging Following 90Y-DOTATATE Treatment.
Autorzy :
Parghane RV; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Mitra A; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Upadhye T; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Rakshit S; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Banerjee S; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Basu S; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Sep; Vol. 45 (9), pp. 714-715.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Tumor Burden*/radiation effects
Coordination Complexes/*therapeutic use
Neuroendocrine Tumors/*pathology
Neuroendocrine Tumors/*radiotherapy
Octreotide/*analogs & derivatives
Organometallic Compounds/*therapeutic use
Receptors, Peptide/*metabolism
Gallium Radioisotopes ; Humans ; Male ; Middle Aged ; Neuroendocrine Tumors/diagnostic imaging ; Neuroendocrine Tumors/metabolism ; Octreotide/therapeutic use
Czasopismo naukowe
Tytuł :
Primitive neuroectodermal tumor of urinary bladder: A case report and literature review.
Autorzy :
Gao L; Department of Urology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University.
Xie W; Department of Urology, the First Affiliated Hospital of Nanchang University.
Li K; Department of Urology, Jiujiang No.1 People's Hospital.
Huang G; Department of Urology, the First Affiliated Hospital of Nanchang University.
Ji Y; Department of Urology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University.
Ou Y; Department of Urology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University.
Chen J; Department of Urology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Nov 06; Vol. 99 (45), pp. e23032.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Cystectomy/*methods
Neuroectodermal Tumors, Primitive/*diagnosis
Urinary Bladder Neoplasms/*pathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/standards ; Chemotherapy, Adjuvant/methods ; Child ; Combined Modality Therapy ; Cyclophosphamide/standards ; Dactinomycin/standards ; Female ; Humans ; Laparoscopy/methods ; Lymph Node Excision/methods ; Male ; Middle Aged ; Neuroectodermal Tumors, Primitive/drug therapy ; Neuroectodermal Tumors, Primitive/surgery ; Treatment Outcome ; Vincristine/standards
SCR Protocol :
VAC protocol
Czasopismo naukowe
Tytuł :
Angiogenesis inhibitors in neuroendocrine tumours: finally coming of age.
Autorzy :
Kunz PL; Department of Medicine, Division of Oncology, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1395-1397.
Typ publikacji :
Journal Article
MeSH Terms :
Angiogenesis Inhibitors/*therapeutic use
Neovascularization, Pathologic/*genetics
Neuroendocrine Tumors/*therapy
Humans ; Neovascularization, Pathologic/pathology ; Neovascularization, Pathologic/therapy ; Neuroendocrine Tumors/epidemiology ; Neuroendocrine Tumors/genetics ; Neuroendocrine Tumors/pathology
Czasopismo naukowe
Tytuł :
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.
Autorzy :
Xu J; Department of Gastrointestinal Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. Electronic address: .
Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Zhou Z; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Li J; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Bai C; Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, China.
Chi Y; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Z; Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu, China.
Xu N; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Li E; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Liu T; Department of Medical Oncology, Zhongshan Hospital of Fudan University, Shanghai, China.
Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Yuan Y; Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li X; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang X; Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, China.
Chen J; Department of Oncology, Jiangsu Cancer Hospital, Nanjing, China.
Ying J; Department of Abdominal Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Yu X; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qin S; People's Liberation Army Cancer Center of Nanjing Jinling Hospital, Nanjing, China.
Yuan X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Deng Y; Department of Medical Oncology, The Sixth Affiliated Hospital, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases l, Sun Yat-sen University, Guangzhou, Guangdong, China.
Xiu D; Department of General Surgery, Peking University Third Hospital, Beijing, China.
Cheng Y; Department of Thoracic Oncology, Jilin Provincial Cancer Hospital, Changchun, China.
Tao M; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jia R; Department of Gastrointestinal Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
Wang W; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Li J; Department of Clinical Development and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
Fan S; Department of Clinical Development and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
Peng M; Department of Clinical Development and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
Su W; Department of Clinical Development and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1500-1512. Date of Electronic Publication: 2020 Sep 20.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiogenesis Inhibitors/*administration & dosage
Drug-Related Side Effects and Adverse Reactions/*pathology
Neuroendocrine Tumors/*drug therapy
Pancreatic Neoplasms/*drug therapy
Adult ; Aged ; Angiogenesis Inhibitors/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; China/epidemiology ; Disease Progression ; Double-Blind Method ; Drug-Related Side Effects and Adverse Reactions/classification ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Neuroendocrine Tumors/epidemiology ; Neuroendocrine Tumors/genetics ; Neuroendocrine Tumors/pathology ; Pancreatic Neoplasms/epidemiology ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/pathology ; Progression-Free Survival ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Unusual giant complex odontoma: A case report.
Autorzy :
Bueno NP; Department of Oral and Maxillofacial Surgery, Prosthesis and Traumatology, School of Dentistry, University of Sao Paulo, Sao-Paulo, SP, Brazil.
Bergamini ML; Department of Stomatology, School of Dentistry, University of Sao Paulo, Sao-Paulo, SP, Brazil.
Elias FM; Department of Oral and Maxillofacial Surgery, Prosthesis and Traumatology, School of Dentistry, University of Sao Paulo, Sao-Paulo, SP, Brazil.
Braz-Silva PH; Department of Stomatology, School of Dentistry, University of Sao Paulo, Sao-Paulo, SP, Brazil; Laboratory of Virology, Institute of Tropical Medicine of Sao Paulo, University of Sao Paulo, Sao Paulo, SP, Brazil.
Ferraz EP; Department of Oral and Maxillofacial Surgery, Prosthesis and Traumatology, School of Dentistry, University of Sao Paulo, Sao-Paulo, SP, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Journal of stomatology, oral and maxillofacial surgery [J Stomatol Oral Maxillofac Surg] 2020 Nov; Vol. 121 (5), pp. 604-607. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Case Reports
MeSH Terms :
Odontogenic Tumors*
Odontoma*/diagnostic imaging
Odontoma*/surgery
Facial Asymmetry ; Humans ; Mandible ; Radiography
Raport
Tytuł :
Feasibility of 177Lu Therapy Monitoring Using Fast Whole-Body SPECT Recordings Provided by a High-Speed 360° CZT Camera.
Autorzy :
Chevalier E; From the Nuclear Medicine Department.
Boursier C; From the Nuclear Medicine Department.
Claudin M; From the Nuclear Medicine Department.
Marie PY; From the Nuclear Medicine Department.; Nancyclotep Imaging Platform, CHRU-Nancy.; INSERM, UMR-1116.
Imbert L; From the Nuclear Medicine Department.; Nancyclotep Imaging Platform, CHRU-Nancy.; INSERM, UMR-1254, Université de Lorraine, Nancy, France.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Nov; Vol. 45 (11), pp. e493-e494.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Neuroendocrine Tumors/*diagnostic imaging
Neuroendocrine Tumors/*radiotherapy
Octreotide/*analogs & derivatives
Organometallic Compounds/*therapeutic use
Single Photon Emission Computed Tomography Computed Tomography/*instrumentation
Whole Body Imaging/*instrumentation
Aged ; Feasibility Studies ; Female ; Humans ; Neuroendocrine Tumors/pathology ; Octreotide/therapeutic use ; Pancreatic Neoplasms/diagnostic imaging ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/radiotherapy ; Phantoms, Imaging ; Radiometry
Czasopismo naukowe
Tytuł :
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study.
Autorzy :
Xu J; Department of Gastrointestinal Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. Electronic address: .
Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Bai C; Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, China.
Wang W; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Li J; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Yu X; Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Li Z; Department of Abdominal Oncology, West China Hospital, Sichuan University, Chengdu, China.
Li E; Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yuan X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chi Y; National Cancer Center and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yin Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lou W; Department of General Surgery, Zhongshan Hospital of Fudan University, Shanghai, China.
Xu N; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiu D; Department of General Surgery, Peking University Third Hospital, Beijing, China.
Wang X; Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, China.
Yuan Y; Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen J; Department of Oncology, Jiangsu Cancer Hospital, Nanjing, China.
Qin S; People's Liberation Army Cancer Center of Nanjing Jinling Hospital, Nanjing, China.
Jia R; Department of Gastrointestinal Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
Lu M; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Cheng Y; Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, China.
Zhou Z; Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Li J; Department of Clinical and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
He J; Department of Clinical and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
Su W; Department of Clinical and Regulatory Affairs, Hutchison MediPharma, Shanghai, China.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. 1489-1499. Date of Electronic Publication: 2020 Sep 20.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Angiogenesis Inhibitors/*administration & dosage
Drug-Related Side Effects and Adverse Reactions/*pathology
Neuroendocrine Tumors/*drug therapy
Pancreatic Neoplasms/*drug therapy
Adult ; Aged ; Angiogenesis Inhibitors/adverse effects ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; China/epidemiology ; Disease Progression ; Double-Blind Method ; Drug-Related Side Effects and Adverse Reactions/classification ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Neuroendocrine Tumors/epidemiology ; Neuroendocrine Tumors/genetics ; Neuroendocrine Tumors/pathology ; Pancreatic Neoplasms/epidemiology ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/pathology ; Progression-Free Survival ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Novel insights into the mixed germ cell-sex cord stromal tumor of the testis: detection of chromosomal aneuploidy and further morphological evidence supporting the neoplastic nature of the germ cell component.
Autorzy :
Michalova K; Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. .
McKenney JK; Department of Pathology, Cleveland Clinic, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland, OH, USA.
Kristiansen G; Department of Pathology, Universitätsklinikum Bonn, 53127, Bonn, Germany.
Steiner P; Bioptical laboratory, Ltd., 301 00, Pilsen, Czech Republic.
Grossmann P; Bioptical laboratory, Ltd., 301 00, Pilsen, Czech Republic.
Putzova M; Bioptical laboratory, Ltd., 301 00, Pilsen, Czech Republic.
Martinek P; Bioptical laboratory, Ltd., 301 00, Pilsen, Czech Republic.
Chottova-Dvorakova M; Department of Physiology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Michal M; Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 323 00, Pilsen, Czech Republic.
Hes O; Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Michal M; Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Nov; Vol. 477 (5), pp. 615-623. Date of Electronic Publication: 2020 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Aneuploidy*
Chromosomes, Human*
Biomarkers, Tumor/*genetics
Neoplasms, Germ Cell and Embryonal/*genetics
Neoplasms, Germ Cell and Embryonal/*pathology
Sex Cord-Gonadal Stromal Tumors/*genetics
Sex Cord-Gonadal Stromal Tumors/*pathology
Testicular Neoplasms/*genetics
Testicular Neoplasms/*pathology
Adult ; Aged ; Biomarkers, Tumor/analysis ; Biopsy ; Comparative Genomic Hybridization ; Genetic Predisposition to Disease ; High-Throughput Nucleotide Sequencing ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Neoplasms, Germ Cell and Embryonal/chemistry ; Phenotype ; Sex Cord-Gonadal Stromal Tumors/chemistry ; Testicular Neoplasms/chemistry
Czasopismo naukowe
Tytuł :
Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes.
Autorzy :
Mei W; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.; Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, China.
Ding Y; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.; Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, China.
Wang S; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.; Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, China.
Jia Y; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China.; Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, China.
Cao F; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China. .; Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, China. .
Li F; Department of General Surgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Beijing, China. .; Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, China. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Nov; Vol. 146 (11), pp. 3049-3061. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphatic Metastasis/*pathology
Neuroendocrine Tumors/*pathology
Pancreatic Neoplasms/*pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Neuroendocrine Tumors/mortality ; Pancreatic Neoplasms/mortality ; Retrospective Studies ; Risk Factors ; SEER Program ; Survival Analysis
Czasopismo naukowe
Tytuł :
Molecular Imaging in the Head and Neck: Diagnosis and Therapy.
Autorzy :
Howard BA; Division of Nuclear Medicine, Department of Radiology, Duke University School of Medicine, DUMC Box 3949, 2301 Erwin Road, Durham, NC 27710, USA. Electronic address: .
Pokaż więcej
Źródło :
Radiologic clinics of North America [Radiol Clin North Am] 2020 Nov; Vol. 58 (6), pp. 1135-1146.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Head and Neck Neoplasms/*diagnostic imaging
Molecular Imaging/*methods
Neuroendocrine Tumors/*diagnostic imaging
Positron-Emission Tomography/*methods
Radiopharmaceuticals/*pharmacology
Female ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/therapy ; Humans ; Iodine Radioisotopes/pharmacology ; Male ; Neuroendocrine Tumors/pathology ; Neuroendocrine Tumors/therapy ; Organometallic Compounds/pharmacology ; Sensitivity and Specificity ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Somatic SDHA mutations in paragangliomas in siblings: Case report of 2 cases.
Autorzy :
Huang YC; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital.; School of Medicine, National Yang-Ming University.
Chang HH; School of Medicine, National Yang-Ming University.; Division of Cardiovascular Surgery, Department of Surgery.
Chen MH; School of Medicine, National Yang-Ming University.; Department of Oncology, Center of Immuno-Oncology.
Huang KH; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital.; School of Medicine, National Yang-Ming University.
Li AF; School of Medicine, National Yang-Ming University.; Department of Pathology, Taipei Veterans General Hospital.
Lin CH; Genome Research Center, National Yang-Ming University, Taipei City, Taiwan.
Shyr YM; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital.; School of Medicine, National Yang-Ming University.
Fang WL; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital.; School of Medicine, National Yang-Ming University.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Oct 09; Vol. 99 (41), pp. e22497.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Electron Transport Complex II/*genetics
Gastrointestinal Stromal Tumors/*genetics
Neoplasms, Multiple Primary/*genetics
Paraganglioma, Extra-Adrenal/*genetics
Stomach Neoplasms/*genetics
Adult ; Female ; Gastrointestinal Stromal Tumors/diagnosis ; Gastrointestinal Stromal Tumors/pathology ; Genetic Testing ; Humans ; Immunohistochemistry ; Middle Aged ; Mutation ; Paraganglioma, Extra-Adrenal/diagnosis ; Paraganglioma, Extra-Adrenal/pathology ; Siblings ; Stomach Neoplasms/diagnosis ; Stomach Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Diffuse primary extra-gastrointestinal stromal tumor of the peritoneum: A rare case report.
Autorzy :
Lu LJ; Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine.
Xu XP; Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine.
Dong F; Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine.
Min J; Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, Zhejiang Province, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Oct 02; Vol. 99 (40), pp. e22493.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Gastrointestinal Stromal Tumors/*pathology
Peritoneal Neoplasms/*pathology
Antineoplastic Agents/therapeutic use ; Gastrointestinal Stromal Tumors/diagnosis ; Gastrointestinal Stromal Tumors/drug therapy ; Humans ; Imatinib Mesylate/therapeutic use ; Male ; Middle Aged ; Peritoneal Neoplasms/diagnosis ; Peritoneal Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.
Autorzy :
Rindi G; Università Cattolica del Sacro Cuore, Rome, Italy. .; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. .
Wiedenmann B; Charité, Campus Virchow Klinikum and Charité Mitte, University Medicine Berlin, Berlin, Germany.
Pokaż więcej
Źródło :
Nature reviews. Endocrinology [Nat Rev Endocrinol] 2020 Oct; Vol. 16 (10), pp. 590-607. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Gastrointestinal Neoplasms*/diagnosis
Gastrointestinal Neoplasms*/physiopathology
Gastrointestinal Neoplasms*/secondary
Gastrointestinal Neoplasms*/therapy
Neuroendocrine Tumors*/complications
Neuroendocrine Tumors*/diagnosis
Neuroendocrine Tumors*/physiopathology
Neuroendocrine Tumors*/therapy
Precision Medicine*
Animals ; Antineoplastic Agents/therapeutic use ; Humans ; World Health Organization
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies